Aspect Biosystems’ $2.7 Billion Collaboration with Novo Nordisk

Wilson Sonsini Goodrich & Rosati advised Aspect Biosystems on the transaction.Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics, and leading global healthcare…

This content is for Standard 1 Year members only.
Login Join Now

Regis Corporation’s Refinancing of Credit Facility

Howard Midstream Energy Partners’ $600 Million High-Yield Offering

Tamboran Resources Corporation’s $75 Million IPO On NYSE

Grupo Albanesi’s US$59,89 Million Notes Offering

ALZ Nutrientes’ US$1,5 Million Series II Notes Issuance

JetSMART’s Authorizations for a New Flight Route

Great Portland Estates’ £350m Rights Issue

Legal & General Investment Management’s Launch Of Long-Term Asset Fund (LTAF)

Liberty v. UK’s Secretary of State for the Home Department

Admaius Capital Partners’ Acquisition of St. Christopher Iba Mar Diop Medical School

Holged’s Acquisition of Kenzi

Sun Pharma’s Acquisition of a Stake in Valstar and Kemipharm

Saudi Aramco’s US$11.2 Billion Shares Offering

National Bank of Egypt’s $1 Billion Loan Facility

WheeKeep’s US$8 Million Series A Funding Round

Zepto’s $665 Million Series F Financing Round

Gokaldas Exports Limited’s Investment in BRFL Textiles

Ocean Industry Development Group’s Bonds Offering

Weil Welcomes Thomas Henry as Co-Head of U.S. Real Estate Practice

Argentina’s Economic Reform Law expected to pass: Top points

Baker McKenzie Welcomes Two Leading Banking and Finance Partners in Johannesburg

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.

Weil Welcomes Thomas Henry as Co-Head of U.S. Real Estate Practice

Baker McKenzie Welcomes Two Leading Banking and Finance Partners in Johannesburg

Sidley adds leading Antitrust partner Corey Roush to Sidley’s Washington DC Office

Aspect Biosystems’ $2.7 Billion Collaboration with Novo Nordisk

Author: Martina Bellini